A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MK-0616 in Adults With Heterozygous Familial Hypercholesterolemia.

Nicholls, Stephen (Primary Chief Investigator (PCI))

Medicine Monash Health

Project: Research

Project Description

HREC Reference Number: HREC/97876/MonH-2023-381811(v2)
Monash Health Local Reference: RES-23-0000-309A
ERM Project ID: 97876

Status	Active
Effective start/end date	2/10/23 → 1/10/28